SCHEMBL4596227

SCHEMBL4596227

CCNc1cc(O)cc(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
CYP3A4 P08684 2/20 0.43
TSHR P16473 2/20 0.43
RECQL P46063 1/20 0.43
BACE1 P56817 1/20 0.42
ADRA2A P08913 2/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
PTGS2 P35354 3/20 0.38
ACHE P22303 1/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35
HSP90AB1 P08238 1/20 0.35
MAPT P10636 2/20 0.34
NQO2 P16083 1/20 0.34
PGK1 P00558 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21635498 0.86 ALDH1A1 (0.50) LMNACYP3A4TSHRRECQLADRA2A
SCHEMBL12229096 0.80 MAPT (0.41) LMNACYP3A4TSHRRECQLADRA2A
SCHEMBL4811576 0.77 SELL (0.42) LMNACYP3A4TSHRRECQLADRA2A
SCHEMBL10934796 0.77 CA1 (0.63) LMNACA12CA1CA2CA7
SCHEMBL55730 0.77 CYP3A4 (0.52) LMNACYP3A4TSHRRECQLACHE
SCHEMBL9187399 0.75 GPR84 (0.51) CYP3A4ADRA2APTGS2
Hydrochloric Acid SCHEMBL3066468 0.75 CYP3A4 (0.50) LMNACYP3A4TSHRRECQLACHE
SCHEMBL27746749 0.75 CYP3A4 (0.50) LMNACYP3A4TSHRRECQLACHE
SCHEMBL440145 0.74 MAPT (0.57) LMNACYP3A4TSHRRECQLADRA2A
Bromide SCHEMBL4725114 0.72 MAPT (0.55) LMNACYP3A4TSHRRECQLADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115584093-A Fluororubber for valves and preparation method thereof 安徽道格思新材料有限公司 2023-01-10 CN claimed
CN-109851958-B High-hardness fluororubber and preparation method thereof 成都菁尚科技有限公司 2020-12-29 CN claimed
CN-109467855-A A kind of fluorubber of high temperature and pressure contracting ratio 江苏奥纳森弹性体技术研究院有限公司 2019-03-15 CN claimed
CN-109401144-A A kind of fluoro-rubber composite of high temperature and pressure contracting ratio and its application 江苏奥纳森弹性体技术研究院有限公司 2019-03-01 CN claimed
CN-109354809-A A kind of fluoro-rubber composite of high Shao Er hardness 江苏奥纳森弹性体技术研究院有限公司 2019-02-19 CN claimed
CN-115584093-A Fluororubber for valves and preparation method thereof 安徽道格思新材料有限公司 2023-01-10 CN disclosed
CN-109354809-B high-Shore-hardness fluororubber composition 江苏奥纳森弹性体技术研究院有限公司 2021-01-08 CN disclosed
CN-109851958-B High-hardness fluororubber and preparation method thereof 成都菁尚科技有限公司 2020-12-29 CN disclosed
CN-109467855-A A kind of fluorubber of high temperature and pressure contracting ratio 江苏奥纳森弹性体技术研究院有限公司 2019-03-15 CN disclosed
CN-109401144-A A kind of fluoro-rubber composite of high temperature and pressure contracting ratio and its application 江苏奥纳森弹性体技术研究院有限公司 2019-03-01 CN disclosed
CN-109354809-A A kind of fluoro-rubber composite of high Shao Er hardness 江苏奥纳森弹性体技术研究院有限公司 2019-02-19 CN disclosed
US-20090163493-A9 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor SERENEX, INC. 2009-06-25 US disclosed
US-20080096887-A1 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor SERENEX, INC. 2008-04-24 US disclosed
EP-1286647-B1 OXIDATION DYEING METHOD FOR KERATINOUS FIBERS HENKEL KGAA (DE) 2008-01-09 EP disclosed
EP-0841329-A1 Method of synthesizing tert-amido-substituted 2-(2'-hydroxyphenyl) benzotriazole compounds in a onestep process EASTMAN KODAK COMPANY (US) 1998-05-13 EP disclosed
US-5739348-A NOBLE METAL CATALYZED HYDROGENATION OR NONCATALYTIC REDUCTIVE RING CLOSURE AND DEACYLATION OF SPECIFIED AZO DYE EASTMAN KODAK COMPANY (US) 1998-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163493-A9 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor HSP90AA1, HSP90AB1, HSPA4 LMNA 4650/4885CYP3A4 1143/4885TSHR 3710/4885
US-20080096887-A1 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor HSP90AA1, HSP90AB1, HSPA4 LMNA 4650/4885CYP3A4 1143/4885TSHR 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.